Zusammenfassung
Das akute Leberversagen ist eine Multisystemerkrankung, die durch eine schwere Leberinsuffizienz mit hepatischer Enzephalopathie gekennzeichnet ist, durch apoptotischen oder nekrotischen Untergang von Leberparenchym verursacht wird und ohne vorbekannte Lebererkrankung auftritt. Die klinische Herausforderung liegt in der frühen Identifizierung von Patienten mit schlechter Prognose und deren rechtzeitiger Listung zur Transplantation. Der vorliegende Beitrag beleuchtet die Grundlagen der Entscheidungsfindung zur Transplantation, aktuelle Aspekte der Intensivtherapie sowie die sklerosierende Cholangitis des Intensivpatienten als Ursache des subakuten Leberversagens.
Abstract
Acute liver failure is a multisystem disease with predominantly sudden and severe hepatic injury and hepatic encephalopathy caused by apoptotic or necrotic hepatocyte damage. The clinical challenge in patients with acute liver failure is to promptly identify those with poor prognosis and refer them for emergency liver transplantation. This review article highlights the main aspects of decision making in the setting of acute liver failure, summarizes new aspects of its critical care management and gives an overview of sclerosing cholangitis in the critically ill patient, an under-recognized disease entity that can progress to acute liver failure.
Literatur
Acharya SK, Bhatia V, Sreenivas V et al (2009) Efficacy of L-ornithine L-aspartate in acute liver failure: a double-blind, randomized, placebo-controlled study. Gastroenterology 136:2159–2168
Ananthakrishnan AN, McGinley EL, Saeian K (2008) Effect of hospital volume and teaching status on outcomes of acute liver failure. Liver Transpl 14:1347–1356
Andrade RJ, Lucena MI, Fernandez MC et al (2005) Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 129:512–521
Antonides C, Berry P, Wendon J et al (2008) The importance of immune dysfunction in determining outcome in acute liver failure. J Hepatol 49:845–861
Bechmann LP, Jochum C, Kocabayoglu P et al (2010) Cytokeratin-18 based modification of the MELD score improves prediction of spontaneous survival after acute liver failure. J Hepatol 53:639–647
Bernal W, Hall C, Karvellas CJ et al (2007) Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology 46:1844–1852
Bernal W, Cross TJS, Auzinger G et al (2009) Outcome after wait-listing for emergency liver transplantation in acute liver failure: a single centre experience. J Hepatol 50:306–313
Bernal W, Auzinger G, Dhawan A et al (2010) Acute liver failure. Lancet 376:190–201
Bernuau J, Nicand E, Durand F (2008) Hepatitis E-associated acute liver failure in pregnancy: an Indian puzzle. Hepatology 48:1380–1382
Bismuth H, Samuel D, Castaing D et al (1995) Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience. Ann Surg 222:109–119
Bower WA, Johns M, Margolis HS et al (2007) Population-based surveillance for acute liver failure. Am J Gastroenterol 102:2459–2463
Brandsaeter B, Hockerstedt K, Friman S et al (2002) Fulminant hepatic failure: outcome after listing for highly urgent liver transplantation – 12 years experience in the nordic countries. Liver Transpl 8:1055–1062
Canbay A (2010) Leberparameter und Einschätzung der Leberleistung. In: Canbay A, Gerken G (Hrsg) Die Leber in der Intensivmedizin. Aesopus, Linkenheim-Hochstetten, S 24–37
Canbay A, Jochum C, Bechmann LP et al (2009) Acute liver failure in a metropolitan area in Germany: a retrospective study (2002–2008). Z Gastroenterol 47:807–813
Christensen E (2010) Glucocorticosteroids in acute alcoholic hepatitis: the evidence of a beneficial effect is getting even weaker. J Hepatol 53:390–391
Cornberg M, Protzer U, Dollinger MM et al (2007) Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virus-Infektion – Upgrade der Leitlinie. Z Gastroenterol 45:1–50
Craig DG, Ford AC, Hayes PC et al (2010) Systematic review: prognostic tests of paracetamol-induced acute liver failure. Aliment Pharmacol Ther 31:1064–1076
Dalton HR, Bendall R, Ijaz S et al (2008) Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis 8:698–709
Dechêne A, Sowa JP, Gieseler RK et al (2010) Acute liver failure is associated with elevated liver stiffness and hepatic stellate cell activation. Hepatology 52:1008–1016
Depka M von (2002) Hämostaseologische Methoden. In: Depka M von (Hrsg) Blutgerinnung – Aktuelle Aspekte der Physiologie, Pathophysiologie, Klinik, Diagnostik, Prophylaxe und Therapie. Uni-Med, Bremen, S 116–128
Dureja P, Lucey MR (2010) The place of liver transplantation in the treatment of severe alcoholic hepatitis. J Hepatol 52:759–764
Engler S, Elsing C, Flechtenmacher C et al (2003) Progressive sclerosing cholangitis after septic shock: a new variant of vanishing bile duct disorders. Gut 52:688–693
Escorsell A, Mas A, de la Mata M, and the Spanish Group for the Study of Acute Liver Failure (2007) Acute liver failure in Spain: analysis of 267 cases. Liver Transpl 13:1389–1395
Escudie L, Franqoz C, Vinel JP et al (2007) Amanita phalloides poisoning: reassessment of prognostic factors and indications for emergency liver transplantation. J Hepatol 46:466–473
Fearing MK, Israel EJ, Sahai I et al (2011) A 9-month-old boy with acute liver failure. N Engl J Med 364:1545–1556
Garg H, Sarin SK, Kumar M et al (2011) Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure. Hepatology 53:774–780
Gelbmann CM, Ruemmele P, Wimmer M et al (2007) Ischemic-like cholangiopathy with secondary sclerosing cholangitis in critically ill patients. Am J Gastroenterol 102:1221–1229
Graham BB, Kaul DR, Saint S et al (2009) Kiss of death. N Engl J Med 360:2564–2568
Hadem J, Schneider AS, Manns MP (2008) Pathophysiologie und Therapie des akuten Leberversagens. Intensivmedizin Up2Date 1:17–33
Hadem J, Stiefel P, Bahr MJ et al (2008) Prognostic implications of lactate, bilirubin and etiology in German patients with acute liver failure. Clin Gastroenterol Hepatol 6:339–345
Hadem J, Tacke F, Bruns T et al (2011) Acute liver failure in Germany 2008–2009: a retrospective analysis by the acute liver failure study group Germany (abstract). J Hepatol 54:S367
Harrison PM, Wendon JA, Gimson AE et al (1991) Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med 324:1852–1857
Harry R, Ausinger G, Wendon J (2002) Clinical importance of adrenal insufficiency in acute hepatic dysfunction. Hepatology 36:395–402
Hui C-K, Cheung WWW, Zhang H-Y et al (2006) Kinetics and risk of de novo hepatitis B infection in HbsAg-negative patients undergoing cytotoxic chemotherapy. Gastroenterology 131:59–68
Jaeger C, Mayer G, Henrich R et al (2006) Secondary sclerosing cholangitis after long-term treatment in an intensive care unit: clinical presentation, endoscopic findings, treatment and follow-up. Endoscopy 38:730–734
Jalan R, Olde Damink SW, Hayes PC et al (2004) Pathogenesis of intracranial hypertension in acute liver failure: inflammation, ammonia and cerebral blood flow. J Hepatol 41:613–620
Jalan R, Williams R, Bernuau J (2006) Paracetamol: are therapeutic doses entirely safe? Lancet 368:2195–2196
Jochum C, Gieseler RK, Gawlista I et al (2009) Hepatitis B-associated acute liver failure: immediate treatment with entecavir inhibits hepatitis B virus replication and potentially its sequelae. Digestion 80:235–240
Katoonizadeh A, Decaestecker J, Wilmer A et al (2007) MELD score to predict outcome in adult patients with non-acetaminophen-induced acute liver failure. Liver Int 27:329–334
Kneiseler G, Bachmann HS, Bechmann LP et al (2010) A rare case of propofol-induced acute liver failure and literature review. Case Rep Gastroenterol 4:57–65
Kulaksiz H, Heuberger D, Engler S et al (2008) Poor outcome in progressive sclerosing cholangitis after septic shock. Endoscopy 40:214–218
Lange CM, Bojunga J, Hofmann WP et al (2009) Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function. Hepatology 50:2001–2006
Larsen FS, Murphy N, Bernal W et al (2011) The prophylactic effect of mild hypothermia to prevent brain edema in patients with acute liver failure: results of a multicenter, randomized, controlled trial (abstract). J Hepatol 54:S26
Lee WM, Hynan LS, Rossaro L et al (2009) Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology 137:856–864
Leithead JA, Ferguson JW, Bates CM et al (2009) The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure. Gut 58:443–449
Lisman T, Caldwell SH, Burroughs AK et al (2010) Hemostasis and thrombosis in patients with liver diasease: the ups and downs. J Hepatol 53:362–371
Mathurin P (2010) The use of corticosteroids in severe alcohol hepatitis: we need to look beyond this controversy. J Hepatol 53:392–393
Mindikoglu AL, Magder LS, Regev A (2009) Outcome of liver transplantation for drug-induced acute liver failure in the United States: analysis of the united network for organ sharing database. Liver Transpl 15:719–729
Müller-Beißenhirtz H (2010) Gerinnungsstörungen bei Lebererkrankungen. In: Canbay A, Gerken G (Hrsg) Die Leber in der Intensivmedizin. Aesopus, Linkenheim-Hochstetten, S 38–65
Murphy N, Auzinger G, Bernal W et al (2004) The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hematology 39:464–470
Norvell JP, Blei AT, Jovanovic BD et al (2007) Herpes simplex virus hepatitis: an analysis of the published literature and institutional cases. Liver Transpl 13:1428–1434
O’Grady JG, Alexander GJ, Hayllar KM et al (1989) Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 97:439–445
O’Grady JG, Schalm SW, Williams R (1993) Acute liver failure: redefining the syndromes. Lancet 342:273–275
Ostapowicz G, Fontana RJ, Schiødt FV et al (2002) Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 137:947–954
Polson J, Lee WM (2005) AASLD position paper: the management of acute liver failure. Hematology 41:1179–1197
Rank N, Michel C, Haertel C et al (2000) N-acetylcysteine increases liver blood flow and improves liver function in septic shock patients: results of a prospective, randomized, double-blind study. Crit Care Med 28:3799–3807
Renner EL (2007) How to decide when to list a patient with acute liver failure for liver transplantation? Clichy or King‘s College criteria, or something else? J Hepatol 46:554–557
Reuben A, Koch DG, Lee WM (2010) Acute Liver Failure Study Group: drug-induced acute liver failure: results of a US multicenter, prospective study. Hepatology 52:2065–2076
Rezende G, Roque-Afonso AM, Samuel D et al (2003) Viral and clinical factors associated with the fulminant course of hepatitis A infection. Hematology 38:613–638
Rolando N, Gimson A, Wade J et al (1993) Prospective controlled trial of selective parenteral and enteral antimicrobial regimen in fulminant liver failure. Hepatology 17:196–201
Ruemmele P, Hofstaedter F, Gelbmann CM (2009) Secondary sclerosing cholangitis. Nat Rev Gastroenterol Hepatol 6:287–295
Saliba F, Camus C, Durand F et al (2008) Randomized controlled multicenter trial evaluating the efficacy and safety of albumin dialysis with MARS in patients with fulminant and subfulminant hepatic failure (abstract). Hepatology 48:4
Schmidt L, Larsen F (2007) MELD score as a predictor of liver failure and death in patients with acetaminophen-induced liver injury. Hepatology 45:789–796
Smilkstein MJ, Knap GL, Kulig KW et al (1998) Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. N Engl J Med 319:1557–1562
Squires RH Jr, Shneider BL, Bucuvalas J et al (2006) Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr 148:652–658
Taylor RM, Davern T, Munoz S et al (2006) Fulminant hepatitis A virus infection in the United States: incidence, prognosis, and outcomes. Hepatology 44:1589–1597
Tillmann HL, Hadem J, Leifeld L et al (2006) Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience. J Viral Hepat 13:256–263
Trey C, Davidson CS (1970) The management of fulminant hepatic failure. Prog Liver Dis 3:282–298
Vaquero J, Polson J, Chung C et al (2003) Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology 125:755–764
Walsh TS, Hopton P, Philips BJ et al (1998) The effect of N-acetylcysteine on oxygen transport and uptake in patients with fulminant hepatic failure. Hepatology 27:1332–1340
Walsh TS, Wigmore SJ, Hopton P et al (2000) Energy expenditure in acetaminophen-induced fulminant hepatic failure. Crit Care Med 28:649–654
Wendon J, Manns MP, Alexander G et al (2010) Acute liver failure: current European perspective (abstract). J Hepatol 52:S13
Westbrook RH, Yeoman AD, Joshi D et al (2010) Outcomes of severe pregnancy-related liver disease: refining the role of transplantation. Am J Transplant 10:2520–2526
Whitfield K, Rambaldi A, Wetterslev J et al (2009) Pentoxifylline for alcoholic hepatitis. Cochrane Database Syst Rev 4:CD007339
Yantorno SE, Kremers WK, Ruf AE et al (2007) MELD is superior to King’s college criteria and Clichy’s criteria to assess prognosis in fulminant hepatic failure. Liver Transpl 13:822–828
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hadem, J., Schneider, A. & Manns, M. Akutes Leberversagen. Internist 52, 804–814 (2011). https://doi.org/10.1007/s00108-010-2793-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00108-010-2793-0